Literature DB >> 18728191

NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons.

Carmela Matrone1, Maria Teresa Ciotti, Delio Mercanti, Roberta Marolda, Pietro Calissano.   

Abstract

Here, we report that interruption of NGF or BDNF signaling in hippocampal neurons rapidly activates the amyloidogenic pathway and causes neuronal apoptotic death. These events are associated with an early intracellular accumulation of PS1 N-terminal catalytic subunits and of APP C-terminal fragments and a progressive accumulation of intra- and extracellular Abeta aggregates partly released into the culture medium. The released pool of Abeta induces an increase of APP and PS1 holoprotein levels, creating a feed-forward toxic loop that might also cause the death of healthy neurons. These events are mimicked by exogenously added Abeta and are prevented by exposure to beta- and gamma-secretase inhibitors and by antibodies directed against Abeta peptides. The same cultured neurons deprived of serum die, but APP and PS1 overexpression does not occur, Abeta production is undetectable, and cell death is not inhibited by anti-Abeta antibodies, suggesting that hippocampal amyloidogenesis is not a simple consequence of an apoptotic trigger but is due to interruption of neurotrophic signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728191      PMCID: PMC2525562          DOI: 10.1073/pnas.0806133105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Receptors that mediate cellular dependence.

Authors:  D E Bredesen; P Mehlen; S Rabizadeh
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

2.  Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor.

Authors:  Areechun Sotthibundhu; Alex M Sykes; Briony Fox; Clare K Underwood; Wipawan Thangnipon; Elizabeth J Coulson
Journal:  J Neurosci       Date:  2008-04-09       Impact factor: 6.167

Review 3.  The role of neuronal growth factors in neurodegenerative disorders of the human brain.

Authors:  B Connor; M Dragunow
Journal:  Brain Res Brain Res Rev       Date:  1998-06

4.  Development of a method for measuring cell number: application to CNS primary neuronal cultures.

Authors:  C Volonté; M T Ciotti; L Battistini
Journal:  Cytometry       Date:  1994-11-01

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.

Authors:  Mark H Tuszynski; Leon Thal; Mary Pay; David P Salmon; Hoi Sang U; Roy Bakay; Piyush Patel; Armin Blesch; H Lee Vahlsing; Gilbert Ho; Gang Tong; Steven G Potkin; James Fallon; Lawrence Hansen; Elliott J Mufson; Jeffrey H Kordower; Christine Gall; James Conner
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

7.  Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis.

Authors:  C Galli; A Piccini; M T Ciotti; L Castellani; P Calissano; D Zaccheo; M Tabaton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

8.  Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes.

Authors:  Rithwick Rajagopal; Zhe-Yu Chen; Francis S Lee; Moses V Chao
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

9.  Nerve growth factor and epidermal growth factor rescue PC12 cells from programmed cell death induced by etoposide: distinct modes of protection against cell death by growth factors and a protein-synthesis inhibitor.

Authors:  M Nakajima; K Kashiwagi; J Ohta; S Furukawa; K Hayashi; T Kawashima; Y Hayashi
Journal:  Neurosci Lett       Date:  1994-08-01       Impact factor: 3.046

10.  Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies.

Authors:  Simona Capsoni; Sabina Giannotta; Antonino Cattaneo
Journal:  Mol Cell Neurosci       Date:  2002-09       Impact factor: 4.314

View more
  66 in total

1.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

2.  Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Authors:  Csilla Ari; Sergiy I Borysov; Jiashin Wu; Jaya Padmanabhan; Huntington Potter
Journal:  Neurobiol Aging       Date:  2014-02-10       Impact factor: 4.673

3.  Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.

Authors:  Yu-Hui Liu; Shu-Sheng Jiao; Ye-Ran Wang; Xian-Le Bu; Xiu-Qing Yao; Yang Xiang; Qing-Hua Wang; Lin Wang; Juan Deng; Jing Li; Xin-Fu Zhou; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2014-07-02       Impact factor: 5.590

Review 4.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

5.  BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

Authors:  Zhi-Hao Wang; Wanqiang Wu; Seong Su Kang; Xia Liu; Zhiping Wu; Junmin Peng; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Xuebo Liu; Jian-Zhi Wang; Keqiang Ye
Journal:  JCI Insight       Date:  2018-08-23

6.  Tyr682 in the Aβ-precursor protein intracellular domain regulates synaptic connectivity, cholinergic function, and cognitive performance.

Authors:  Carmela Matrone; Siro Luvisetto; Luca R La Rosa; Robert Tamayev; Annabella Pignataro; Nadia Canu; Li Yang; Alessia P M Barbagallo; Fabrizio Biundo; Franco Lombino; Hui Zheng; Martine Ammassari-Teule; Luciano D'Adamio
Journal:  Aging Cell       Date:  2012-10-12       Impact factor: 9.304

7.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

8.  C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively.

Authors:  Huiping Xie; Zhimin Xiao; Jian Huang
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

9.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

Review 10.  Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan.

Authors:  S M Rothman; M P Mattson
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.